Business Context and Reporting Period
Company: Curis, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2025
Event: Filing of a prospectus supplement under a universal shelf registration statement (Form S-3) to offer and sell up to $8,137,047 of common stock.
Key Financial Metrics
This filing is a current report regarding a capital raising mechanism and does not contain audited financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The filing text does not provide a clear value for these operational financial indicators.
Material Changes
- Prospectus Update: The Company filed a new prospectus supplement on August 8, 2025, replacing a prior prospectus dated April 12, 2024, which was terminated on July 1, 2025.
- Offering Size: The new supplement authorizes the offer and sale of shares with an aggregate offering price of up to $8,137,047.
- Agreement Status: The Amended and Restated Sales Agreement with agents Cantor Fitzgerald & Co. and JonesTrading Institutional Services LLC remains in full force and effect.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the legal opinion issued by Wilmer Cutler Pickering Hale and Dorr LLP regarding the shares. It explicitly states that this report does not constitute an offer to sell or a solicitation of an offer to buy securities in jurisdictions where such actions would be unlawful.
Risks and Contingencies: The filing notes standard securities law restrictions, stating that sales will only occur in states where registration or qualification is complete. No specific operational risks or contingencies are detailed in this specific 8-K text.
Investor Verification Checklist
- Verify the current market price of Curis, Inc. (CRIS) to assess the potential dilution from the $8.1 million offering.
- Review the full Prospectus Supplement (referenced in the filing) for specific terms of the sale agreement.
- Confirm the Company's current cash position and burn rate in the most recent 10-Q or 10-K to understand the necessity of this capital raise.
- Check for any subsequent filings regarding the actual execution of share sales under this new prospectus.